Clinical trial Recruiting at 4 sites Interventional Ages 30 to 90

Evaluating strategies to reduce unnecessary heart imaging tests for stable chest pain

Official title: Optimal Evaluation of Stable Chest Pain to Reduce Unnecessary Utilization of Cardiac Imaging Testing

Run by Tianjin Chest Hospital · NCT05640752 · Data updated 2026-11-12

This study is testing two different ways to see if they can help doctors better identify patients with stable chest pain who don’t need unnecessary heart imaging tests.

Quick facts

Study typeInterventional
Ages30 Years to 90 Years
SexAll
Enrollment800 (estimated)
SponsorTianjin Chest Hospital
Academic / other
Locations4 sites (Beijing, Beijing Municipality and 3 other locations)
StatusRecruiting
StartedDecember 11, 2023
Main results expectedDecember 11, 2024
Study endsDecember 11, 2025
Registry record updatedDecember 24, 2024
Trial IDNCT05640752 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 30 and older with stable chest pain suggestive of chronic coronary syndrome and no history of coronary artery disease.

Probably not a fit

Patients with a history of coronary artery disease, clinically unstable conditions, or those who have undergone cardiac imaging within the past year may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The OPERATE trial aims to improve the evaluation of patients with stable chest pain suggestive of chronic coronary syndrome by comparing two diagnostic strategies based on current guidelines. This multicenter, randomized controlled trial will include 800 subjects who will be assigned to either the NICE or ESC strategy to determine which approach better identifies low-risk patients who may not benefit from coronary computed tomography angiography (CCTA). The primary goal is to assess the rates of CCTA without obstructive coronary artery disease (CAD) and to evaluate the safety of both strategies over a one-year follow-up period. By optimizing diagnostic strategies, the study seeks to minimize unnecessary imaging tests and improve patient management.

Why it matters

Potential benefit: If successful, this study could lead to more accurate identification of low-risk patients, reducing unnecessary imaging tests and associated healthcare costs.

How similar studies have gone: Previous studies have explored similar diagnostic strategies, but this trial aims to provide prospective data on their effectiveness in clinical practice.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria

1. SCP or equivalenta suggestive of CCS and clinically stability
2. No history of CAD (prior myocardial infarction, CR or any CAD documented by previous CIT)
3. Age ≥30 years
4. Willing and able to provide informed consent

Exclusion criteria

1. Prior CIT within 1 year prior to randomization
2. Clinically instability (e.g. cardiogenic shock, ACS, severe arrhythmias or NYHA III or IV heart failure)
3. Non-sinus rhythm
4. Concomitant participation in another clinical trial
5. Complex structural heart disease
6. Non-cardiac illness with life expectancy \< 2 years
7. Allergy to iodinated contrast agent
8. Estimated glomerular filtration rate\<60 ml/min/1.73m2 within 90 days
9. Body mass index \>35kg/m2
10. Expressing a clear preference for undergoing CIT or not
11. Pregnancy

Where it's running

  • Beijing Chaoyang Hospital
    Beijing, Beijing Municipality, China
    Recruiting
  • Hebei Petrochina Central Hospital
    Lanfang, Hebei, China
    Recruiting
  • Tianjin First Central Hospital
    Tianjin, Tianjin Municipality, China
    Recruiting
  • Tianjin Chest Hospital
    Tianjin, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.